Literature DB >> 11983911

Generation of functional antigen-specific T cells in defined genetic backgrounds by retrovirus-mediated expression of TCR cDNAs in hematopoietic precursor cells.

Lili Yang1, Xiao-Feng Qin, David Baltimore, Luk Van Parijs.   

Abstract

We have developed an alternative to transgenesis for producing antigen-specific T cells in vivo. In this system, clonal naive T cells with defined antigen specificity are generated by retrovirus-mediated expression of T cell antigen receptor cDNAs in RAG1-deficient murine hematopoietic precursor cells. These T cells can be stimulated to proliferate and produce cytokines by exposure to antigen in vitro, and they become activated and expand in vivo after immunization. IL-2-deficient T cells generated by this technique show decreased proliferation and cytokine production, both of which can be rescued by exogenous addition of this growth factor. Thus, retrovirus-mediated expression of T cell antigen receptor cDNAs in hematopoietic precursor cells permits the rapid and efficient analysis of the life history of antigen-specific T cells in different genetic backgrounds and may allow for the long-term production of antigen-specific T cells with different functional properties for prophylactic and therapeutic purposes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11983911      PMCID: PMC122927          DOI: 10.1073/pnas.092154599

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  51 in total

Review 1.  Different modes of pathogenesis in T-cell-dependent autoimmunity: clues from two TCR transgenic systems.

Authors:  H Ji; A S Korganow; S Mangialaio; P Höglund; I André; F Lühder; A Gonzalez; L Poirot; C Benoist; D Mathis
Journal:  Immunol Rev       Date:  1999-06       Impact factor: 12.988

Review 2.  The RAG proteins and V(D)J recombination: complexes, ends, and transposition.

Authors:  S D Fugmann; A I Lee; P E Shockett; I J Villey; D G Schatz
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

3.  Linear differentiation of cytotoxic effectors into memory T lymphocytes.

Authors:  J T Opferman; B T Ober; P G Ashton-Rickardt
Journal:  Science       Date:  1999-03-12       Impact factor: 47.728

4.  Retroviral expression in embryonic stem cells and hematopoietic stem cells.

Authors:  S R Cherry; D Biniszkiewicz; L van Parijs; D Baltimore; R Jaenisch
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

Review 5.  Structural basis of T cell recognition.

Authors:  K C Garcia; L Teyton; I A Wilson
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

6.  Transfer of specificity for human immunodeficiency virus type 1 into primary human T lymphocytes by introduction of T-cell receptor genes.

Authors:  L J Cooper; M Kalos; D A Lewinsohn; S R Riddell; P D Greenberg
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

7.  Autoimmunity as a consequence of retrovirus-mediated expression of C-FLIP in lymphocytes.

Authors:  L Van Parijs; Y Refaeli; A K Abbas; D Baltimore
Journal:  Immunity       Date:  1999-12       Impact factor: 31.745

8.  Functional reconstitution of class II MHC-restricted T cell immunity mediated by retroviral transfer of the alpha beta TCR complex.

Authors:  K Fujio; Y Misaki; K Setoguchi; S Morita; K Kawahata; I Kato; T Nosaka; K Yamamoto; T Kitamura
Journal:  J Immunol       Date:  2000-07-01       Impact factor: 5.422

9.  Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death.

Authors:  L Van Parijs; Y Refaeli; J D Lord; B H Nelson; A K Abbas; D Baltimore
Journal:  Immunity       Date:  1999-09       Impact factor: 31.745

10.  V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations.

Authors:  A Villa; C Sobacchi; L D Notarangelo; F Bozzi; M Abinun; T G Abrahamsen; P D Arkwright; M Baniyash; E G Brooks; M E Conley; P Cortes; M Duse; A Fasth; A M Filipovich; A J Infante; A Jones; E Mazzolari; S M Muller; S Pasic; G Rechavi; M G Sacco; S Santagata; M L Schroeder; R Seger; D Strina; A Ugazio; J Väliaho; M Vihinen; L B Vogler; H Ochs; P Vezzoni; W Friedrich; K Schwarz
Journal:  Blood       Date:  2001-01-01       Impact factor: 22.113

View more
  29 in total

1.  Precursor B cell receptor signaling activity can be uncoupled from surface expression.

Authors:  F Betul Guloglu; Christopher A J Roman
Journal:  J Immunol       Date:  2006-06-01       Impact factor: 5.422

2.  IND-Enabling Studies for a Clinical Trial to Genetically Program a Persistent Cancer-Targeted Immune System.

Authors:  Cristina Puig-Saus; Giulia Parisi; Angel Garcia-Diaz; Paige E Krystofinski; Salemiz Sandoval; Ruixue Zhang; Ameya S Champhekar; James McCabe; Gardenia C Cheung-Lau; Nhat A Truong; Agustin Vega-Crespo; Marie Desiles S Komenan; Jia Pang; Mignonette H Macabali; Justin D Saco; Jeffrey L Goodwin; Brad Bolon; Christopher S Seet; Amelie Montel-Hagen; Gay M Crooks; Roger P Hollis; Beatriz Campo-Fernandez; Daniela Bischof; Kenneth Cornetta; Eric H Gschweng; Celia Adelson; Alexander Nguyen; Lili Yang; Owen N Witte; David Baltimore; Begonya Comin-Anduix; Donald B Kohn; Xiaoyan Wang; Paula Cabrera; Paula J Kaplan-Lefko; Beata Berent-Maoz; Antoni Ribas
Journal:  Clin Cancer Res       Date:  2018-11-08       Impact factor: 12.531

3.  A Pilot Trial of the Combination of Transgenic NY-ESO-1-reactive Adoptive Cellular Therapy with Dendritic Cell Vaccination with or without Ipilimumab.

Authors:  Theodore S Nowicki; Beata Berent-Maoz; Gardenia Cheung-Lau; Rong Rong Huang; Xiaoyan Wang; Jennifer Tsoi; Paula Kaplan-Lefko; Paula Cabrera; Justin Tran; Jia Pang; Mignonette Macabali; Ivan Perez Garcilazo; Ignacio Baselga Carretero; Anusha Kalbasi; Alistair J Cochran; Catherine S Grasso; Siwen Hu-Lieskovan; Bartosz Chmielowski; Begoña Comin-Anduix; Arun Singh; Antoni Ribas
Journal:  Clin Cancer Res       Date:  2018-12-20       Impact factor: 12.531

4.  Lentiviral calnexin-modified dendritic cells promote expansion of high-avidity effector T cells with central memory phenotype.

Authors:  Bei Wang; Shuhong Han; Lily Lien; Lung-Ji Chang
Journal:  Immunology       Date:  2009-09       Impact factor: 7.397

5.  Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors.

Authors:  Johannes L Zakrzewski; David Suh; John C Markley; Odette M Smith; Christopher King; Gabrielle L Goldberg; Robert Jenq; Amanda M Holland; Jeremy Grubin; Javier Cabrera-Perez; Renier J Brentjens; Sydney X Lu; Gabrielle Rizzuto; Derek B Sant'Angelo; Isabelle Riviere; Michel Sadelain; Glenn Heller; Juan Carlos Zúñiga-Pflücker; Chen Lu; Marcel R M van den Brink
Journal:  Nat Biotechnol       Date:  2008-03-30       Impact factor: 54.908

6.  IL-13Rα1 is a surface marker for M2 macrophages influencing their differentiation and function.

Authors:  Mermagya Dhakal; John C Hardaway; Fatma Betul Guloglu; Mindy M Miller; Christine M Hoeman; Adam A Zaghouani; Xiaoxiao Wan; Linda M Rowland; Jason A Cascio; Michael P Sherman; Habib Zaghouani
Journal:  Eur J Immunol       Date:  2014-01-13       Impact factor: 5.532

7.  Therapeutic potential of a tumor-specific, MHC-unrestricted T-cell receptor expressed on effector cells of the innate and the adaptive immune system through bone marrow transduction and immune reconstitution.

Authors:  Nehad M Alajez; Jan Schmielau; Mark D Alter; Michael Cascio; Olivera J Finn
Journal:  Blood       Date:  2005-03-03       Impact factor: 22.113

8.  Long-term in vivo provision of antigen-specific T cell immunity by programming hematopoietic stem cells.

Authors:  Lili Yang; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-09       Impact factor: 11.205

9.  Subtle affinity-enhancing mutations in a myelin oligodendrocyte glycoprotein-specific TCR alter specificity and generate new self-reactivity.

Authors:  Akshata Udyavar; Rajshekhar Alli; Phuong Nguyen; Lesley Baker; Terrence L Geiger
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

10.  Retrogenic modeling of experimental allergic encephalomyelitis associates T cell frequency but not TCR functional affinity with pathogenicity.

Authors:  Rajshekhar Alli; Phuong Nguyen; Terrence L Geiger
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.